3型肌壁间子宫肌瘤对体外受精-卵胞浆内单精子注射结局的影响:一项回顾性队列研究
该回顾性队列研究纳入2009年1月1日至2016年12月31日在本中心接受IVF-ICSI的女性,将151例3型肌壁间子宫肌瘤患者与453例匹配对照比较。结果显示3型肌瘤组植入率、临床妊娠率和活产率显著降低,临床流产率无显著差异;肌瘤单发直径或总直径>2.0 cm者不良影响显著,≤2.0 cm者结局无显著差异。
要点
- 3型肌壁间子宫肌瘤患者IVF-ICSI的植入率、临床妊娠率和活产率显著低于匹配对照。
- 3型肌瘤组与对照组临床流产率无显著差异。
- 肌瘤单发直径或总直径>2.0 cm者结局显著降低,≤2.0 cm者无显著差异。
核心结论
- 作者认为3型肌瘤对IVF-ICSI患者的植入率、临床妊娠率和活产率有负面影响,但不显著增加临床流产率。
- 3型肌瘤在总直径或单发直径>2.0 cm的女性中不良影响显著。
研究设计与样本
- 回顾性队列研究,在大学附属生殖医学中心开展。
- 纳入2009年1月1日至2016年12月31日在本中心接受IVF-ICSI的所有女性。
- 151例3型肌壁间子宫肌瘤患者与453例对照按年龄(±1岁)、周期数、不孕类型、控制性卵巢刺激方案及经阴道超声无子宫肌瘤进行1:3匹配。
主要发现
- 3型肌瘤组使用「其他方案」进行控制性卵巢刺激的比例显著高于对照组(P<.001)。
- 3型肌瘤组植入率显著低于对照组。
- 3型肌瘤组活产率和临床妊娠率也低于对照组。
- 两组临床流产率无显著差异。
- 单发直径或总直径>2.0 cm的3型肌瘤患者活产率、临床妊娠率和植入率均显著低于相应对照;≤2.0 cm者IVF-ICSI结局与相应对照无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the influence of type 3 intramural fibroids on in vitro fertilization-intracytoplasmic sperm injection (IVF-ICSI) outcomes. DESIGN: Retrospective cohort study. SETTING: University-based reproductive medicine center. PATIENT(S): All women undergoing IVF-ICSI from January 1, 2009, to December 31, 2016, in our unit. INTERVENTION(S): Each woman was matched with three separate control subjects of the same age (±1 year), number of cycles, type of infertility (primary or secondary), type of protocol used for controlled ovarian hyperstimulation (COH), and no uterine fibroids identified by transvaginal ultrasound. MAIN OUTCOME MEASURE(S): Implantation, clinical pregnancy, clinical miscarriage, and live birth rates. RESULT(S): We included 151 patients with type 3 intramural fibroids and 453 matched control subjects who underwent IVF-ICSI. The rate of "other protocol" used in COH was significantly higher in women with type 3 fibroids than in the control subjects (P<.001). The experimental group had a significantly lower implantation rate. Type 3 fibroids also resulted in a lower frequency of live births and clinical pregnancy. There was no significant difference between the groups in the rate of clinical miscarriage. Compared with the corresponding control subjects, patients with type 3 fibroids with a single fibroid diameter (SD) or total reported fibroid diameter (TD) >2.0 cm also had significantly lower rates of live birth, clinical pregnancy, and implantation. Type 3 fibroids with SD or TD ≤2.0 cm had no significant difference in IVF-ICSI outcomes compared with corresponding control subjects. CONCLUSION(S): Our results suggest that type 3 fibroids exert a negative impact on the rates of implantation, clinical pregnancy, and live birth in patients undergoing IVF-ICSI, but do not significantly increase the clinical miscarriage rate. The deleterious impact of type 3 fibroids was remarkable in women with type 3 fibroids with TD or SD >2.0 cm.
引用
- Yan L, Yu Q, Zhang YN, et al. Effect of type 3 intramural fibroids on in vitro fertilization-intracytoplasmic sperm injection outcomes: a retrospective cohort study. Fertil Steril. 2018. PMID: 29605409. doi:10.1016/j.fertnstert.2018.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。